Impact of Sacubitril–Valsartan Treatment on Diastolic Function and Right Ventricular Function in Patient with Heart Failure with Reduced Ejection Fraction

Safety and Efficacy of Sacubitril ̸ Valsartan drug in Heart Failure Patients

Impact of Sacubatril/Valsartan on Myocardial and Hepatic Stiffness in Heart Failure patients with Reduced Ejection Fraction (HFrEF)

Efficacy and safety of (Sacubitril-Valsartan) Combination on Patients With congestive Heart Failure

Effect of eplerenon on heart failure in patients with paroxysmal Atrial Fibrillation and ejection fraction ≥ 45%.

Safety and Efficacy of Sacubitril/Valsartan Early Initiation in Hospitalized Patients with Heart Failure and Reduced Ejection Fraction

IMPACT OF CARDIAC REHABILITATION ON PATIENTS WITH HEART FAILURE WITH PRESERVED EJECTION FRACTION

EFFECT OF MODERN VERSUS STANDARD OF CARE ANTI-FAILURE MEDICATIONS ON LEFT VENTRICULAR FUNCTION IN HEART FAILURE PATIENTS WITH REDUCED EJECTION FRACTION AS DETECTED BY2D SPECKLE TRACKING ECHOCARDIOGRAPHY

Unlocking Heart Failure's Secret Weapon: The Transformative Impact of Sodium-Glucose Cotransporter-2 Inhibitors on Heart Failure with Reduced Ejection Fraction

Prognostic Value of Asymptomatic Ventricular Arrhythmia on Ambulatory ECG Monitoring in Chronic Heart Failure with Reduced Ejection Fraction